Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |